Evogene (EVGN) Reports Q1 Loss of $0.13/Share

Evogene (NYSE: EVGN) reported Q1 EPS of ($0.13), versus ($0.13) reported last year. Revenue for the quarter came in at $2 million, versus $2.7 million reported last year.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Creatd files Form S-1 and reports Q1 2026 financial results
• AMC Entertainment prices $200M stock offering to redeem senior notes